Enriqueta Felip, MD
Vall d'Hebron Hospital, Barcelona, Spain · Vall d'Hebron University Hospital · HOSPITAL VALL D'HEBRON (Barcelona)
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Enriqueta Felip, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:41 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT06564844 · A Phase III, Randomised Study of Adjuvant Dato-DXd in Combination With Rilvegostomig or Rilvegostomig Monotherapy Versus Standard of Care, Following Complete Tumour Resection, in Participants With Stage I Adenocarcinoma NSCLC Who Are ctDNA-positive or Have High-risk Pathological FeaturesAstraZeneca · active not recruiting · Non-small Cell Lung Cancer · principal investigator
- Ph3NCT03762018 · BEAT-meso: Bevacizumab and Atezolizumab in Malignant Pleural MesotheliomaETOP IBCSG Partners Foundation · completed · Pleural Mesothelioma Malignant Advanced · study chair
- Ph2NCT03445000 · ALEctinib for the Treatment of Pretreated RET-rearranged Advanced Non-small Cell Lung CancerETOP IBCSG Partners Foundation · terminated · Non-small Cell Lung Cancer, Non-small Cell Lung Cancer Metastatic, Non-small Cell Lung Cancer Recurrent · study chair
- Ph3NCT00913705 · Neoadjuvant or Adjuvant Chemotherapy in Patients With Operable Non-small-cell Lung CancerSpanish Lung Cancer Group · completed · Non-Small-Cell Lung Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:41 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in non-small cell lung cancer.